Format

Send to

Choose Destination
Aust N Z J Ophthalmol. 1999 Dec;27(6):431-2.

Intravitreal triamcinolone and elevated intraocular pressure.

Author information

1
rwingate@internet-australia.com

Abstract

PURPOSE:

To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise.

METHODS:

A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied.

RESULTS:

Approximately 30% of the study group developed a significant rise (> or =5 mm Hg) in intraocular pressure above baseline during the first 3 months.

CONCLUSIONS:

Patients considering this form of treatment should be fully informed of the known risks of intraocular injections of steroids.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center